Literature DB >> 7046844

Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations.

M A Lichtman, J M Rowe.   

Abstract

A small proportion of patients with acute or chronic leukemia has an extraordinarily high blood leukocyte count. These high counts can result in a very high fractional volume of leukocytes (leukocrit), which is also a function of the mean leukocyte volume in different types of leukemia. Despite a high fractional volume of leukocytes, bulk viscosity of blood is usually not increased because a decrement in the fractional volume of erythrocytes accompanies the increase in leukocytes. Nevertheless, the excessive numbers of leukocytes present two major problems: first, they can seriously affect flow in the circulation of the lung, brain, and less often, other organs by obstructing microchannels or by forming aggregates and white thrombi in small veins. Moreover, leukemic blasts may compete for oxygen in the microcirculation and they may be invasive, damaging vessel walls. Second, their rapid destruction in response to cytotoxic drugs causes metabolic disturbances, especially uric acid accumulation, which can lead to obstructive uropathy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7046844

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Bilateral sequential audiovestibular loss as an initial manifestation of chronic myelogenous leukemia.

Authors:  Hyun-Ah Kim; Hyon-Ah Yi; Hyuk-Won Chang; Young-Rok Do; Hyung Lee
Journal:  Neurol Sci       Date:  2013-09-26       Impact factor: 3.307

2.  Chemotherapy exposure increases leukemia cell stiffness.

Authors:  Wilbur A Lam; Michael J Rosenbluth; Daniel A Fletcher
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

3.  Analysis of the effects of measured white blood cell entrance times on hemodynamics in a computer model of a microvascular bed.

Authors:  B M Fenton; D W Wilson; G R Cokelet
Journal:  Pflugers Arch       Date:  1985-04       Impact factor: 3.657

4.  Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil.

Authors:  L C O Oliveira; L G M Romano; B P A Prado-Junior; D T Covas; E M Rego; G C De Santis
Journal:  Med Oncol       Date:  2009-11-25       Impact factor: 3.064

5.  Leukocyte Depletion by Therapeutic Leukocytapheresis in Patients with Leukemia.

Authors:  Kristina Hölig; Rainer Moog
Journal:  Transfus Med Hemother       Date:  2012-07-26       Impact factor: 3.747

6.  The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia.

Authors:  Rosa Nguyen; Sima Jeha; Yinmei Zhou; Xueyuan Cao; Cheng Cheng; Deepa Bhojwani; Patrick Campbell; Scott C Howard; Jeffrey Rubnitz; Raul C Ribeiro; John T Sandlund; Tanja Gruber; Hiroto Inaba; Ching-Hon Pui; Monika L Metzger
Journal:  Pediatr Blood Cancer       Date:  2016-05-17       Impact factor: 3.167

7.  Cell cycle-dependence of HL-60 cell deformability.

Authors:  M A Tsai; R E Waugh; P C Keng
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

8.  Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells.

Authors:  Garth W Tormoen; Olivia Recht; András Gruber; Ross L Levine; Owen J T McCarty
Journal:  Phys Biol       Date:  2013-10-08       Impact factor: 2.583

9.  Passive mechanical behavior of human neutrophils: effects of colchicine and paclitaxel.

Authors:  M A Tsai; R E Waugh; P C Keng
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

10.  Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome.

Authors:  Antonio Ruggiero; G Attinà; M Piastra; P Maurizi; S Mastrangelo; D Pietrini; R Riccardi
Journal:  Int J Hematol       Date:  2009-05-23       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.